CD4 and tuberculosis: This report describes our experience applying a comprehensive screening program (including both CXR and sputum culture) to both symptomatic and asymptomatic ambulatory HIV-infected subjects with CD4 counts ≥ 200 being evaluated for a TB vaccine trial in Tanzania.